The Amgen Foundation and the Faculty of Arts and Sciences at Harvard University (Harvard FAS) today announced the global launch of LabXchange™, a free online scienc...

The National Institute for Health and Care Excellence (NICE) has released a draft guidance not recommending Janssen’s Stelara (ustekinumab) for moderately to severel...

UK-based PhoreMost has announced that it has entered into a multi-project collaboration with Otsuka Pharmaceutical, a company dedicated to the research and developme...

Jazz Pharmaceuticals has received a European Marketing Authorisation for Sunosi (solriamfetol) as a treatment for excessive daytime sleepiness in adults with na...

Platform gives researchers access to previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis,...

End-to-end robotic platform provides biotechnology companies, pharmaceutical corporations and academic centres with cost-effective and reproducible drug discovery da...

PF-05251749 complements the company’s pipeline of potential disease-modifying therapies for Alzheimer’s and Parkinson’s diseases. Biogen has agreed to acquire from...

Web-based platform provides broad access to the first-ever cloud laboratory to integrate automated biology and chemistry research capabilities in a closed-loop syste...

Multiple options provide increased flexibility for sponsors. Catalent has launched FlexDirect, a new direct-to-patient service for clinical trials. The FlexDirect ...

After last year’s unexpected passing of founder and long-time helmsman Thomas Neff, FibroGen needed a permanent successor—and with its big roxadustat launch looming,...